◆ 会议时间：2026年4月23-25日
◆ 会议地点：韩国 首尔(Seoul)

◆ 会议简介：

2026年世界乳腺癌学术大会(GBCC2025)将于2026年4月23-25日在韩国首尔举行。

全球乳腺癌大会(GBCC)起始于2007年，是在韩国召开的亚洲最大最具影响力的乳腺癌会议之一，会议由韩国乳腺癌学会主办、韩国乳腺癌基金会支持，每年乳腺癌领域的众多专家学者聚集一堂，共同探讨有效诊断和治疗乳腺癌以及提高妇女健康的科学方法；GBCC原为每两年举办一次，自2016年开始，改为每年举办一次。GBCC汇聚了包括医学人士、科研人员、政策制定者、患者和监护人等来自社会各届宣的专业人士，共同探讨多种科学策略，有效地诊断和治疗乳腺癌，促进妇女健康。每届GBCC都有来自世界各地的一千三百余名专业人士与会。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)。

世界乳腺癌学术大会
GBCC 2026 - Global Breast Cancer Conference 2026

Date:
April 23-25, 2026

Venue:
Seoul, Korea

Hosted by:
Korean Breast Cancer Society

摘要征文投稿：

• Abstract Submission Open: November 1, 2025
• Abstract Submission Deadline: February 1st (Sun.) 23:59 KST, 2026
• Notification of Acceptance: In Mid of March, 2026

点此提交摘要>>>Submit Abstract>>>

STEP 01
Log in or sign up to GBCC 2026 registration system.

STEP 02
Click [My Page] – [Abstract] button on the website, and fill out the abstract form and complete the submission.

STEP 03
Check your email for acceptance notification.

Abstract Format

• Abstracts should be submitted online in English.
• The abstract structure should be as follows:
  - Abstract should be structured into the following headings: Background, Methods, Result, and Conclusion.
  - Abstract should not exceed 300 words. (Excluding Abstract Title and Spaces)
• The maximum number of authors is 30 per abstract.
• You may include one (1) figure or table in your abstract.
• If an author is affiliated with hospital as well as university, please enter the name of the hospital for which he/she works.

GBCC Academic Award (Best, Excellence, Honorable Mention)

• Authors of the top 8 submitted abstract will be assigned to the General Session to present on-site.
• The awardees will be determined through on-site evaluation conducted during the General Session I, II.
• Please refer to the GBCC Academic Award page for more detailed information.

Conflicts of Interest

• The conflict of interest policy requirements applies to all abstract authors. Any potential conflict of interest must be indicated upon abstract submission.
  It is the responsibility of the Presenting Author to obtain disclosure information from all co-authors and to provide disclosure of all interests and relationships. This includes any financial or other relationships with commercial entities whose products or services are related to the subject matter in the manuscript, or sociopolitical issues that can cause conflict.

Encore Abstract Submission

• We are accepting Trial-in-Progress submissions and encore submissions.
• Encore submissions must:
• Have been presented solely in abstract form, including publication in conference proceedings. (Submissions which was already published in the full publication form in journals are NOT accepted.
• Include significant additional data from the previous presentation (as determined by the review committee).
• Include the abstract title, co-authors listed, the full abstract, and indicate if this is an encore presentation and, if so, where it was previously presented. This information should be presented both in abstract and in poster.
• It is the sole responsibility of the author to follow these rules.
• The first author will be responsible for obtaining, and, upon request, showing proof that written permission has been obtained from the copyright holder of the original abstract publication(s).
• Please note that encore abstracts will not be considered for the GBCC Academic Award.

Acceptance Notification

• Abstract acceptance will be notified by e-mail.
• The decision of the Scientific Committee regarding abstract acceptance is final. While authors’ presentation preferences will be taken into consideration, the Committee may assign an alternative format if deemed appropriate. Please note that the decision cannot be appealed.
• The first author or corresponding author should reply to the notification of acceptance of their abstract for attendance confirmation.

Abstract Modification or Withdrawal

• You can modify or withdraw your abstract on the submission online page within deadline.
• The request for modification or withdrawal after the abstract submission deadline must be submitted through email (gbccabs@intercom.co.kr).
• The first author or corresponding author may request a correction of error (e.g., typos, misspellings, grammatical errors).
• If the presenting author does not register for GBCC 2026 by the registration deadline, his/her abstract will be automatically withdrawn.

Dear Colleagues,

It is our great pleasure and honor to welcome you to the Global Breast Cancer Conference 2026 (GBCC 2026), which will take place from April 23 (Thu) to 25 (Sat), 2026, at the Grand Walkerhill Seoul, Korea.

Since its establishment in 2007, GBCC has evolved into one of the most representative and influential international conferences dedicated to breast cancer. Each year, it brings together distinguished experts, researchers, policymakers, and healthcare professionals from around the world, serving as a vital forum for sharing knowledge, advancing clinical practice, and promoting meaningful collaboration across borders.

Throughout its journey, GBCC has pursued a mission of innovation, inclusiveness, and inspiration. From cutting-edge research presentations to policy discussions, from educational programs for young doctors to collaborative sessions with partner societies, GBCC continues to expand the boundaries of academic and clinical exchange, bridging science and humanity for the benefit of patients worldwide.

The upcoming GBCC 2026 will once again offer a diverse and forward-looking scientific program. It will feature plenary and special lectures by world-renowned speakers, joint sessions with international societies, interactive sessions highlighting multidisciplinary approaches, and forums designed to empower the next generation of breast cancer specialists. Through these sessions, we hope to foster deeper dialogue, fresh perspectives, and lasting partnerships.
We would like to extend our heartfelt gratitude to all our international collaborators, supporting societies, sponsors, and participants for their unwavering trust, dedication, and continued engagement. GBCC’s achievements over the years have been made possible through your passion and commitment to a shared goal, the advancement of breast cancer care.

We sincerely invite you to join us in Seoul for GBCC 2026.
Let us come together once again to share knowledge, strengthen friendships, and shape a brighter future for breast cancer patients around the world.

We look forward to welcoming you to Seoul!
Thank you.  

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。